173
IRUS Total
Downloads
  Altmetric

Exome-wide association study of plasma lipids in >300,000 individuals.

File Description SizeFormat 
GLGC_writeup_Nat_Genet_Revision2_091317_SK_clean.docxAccepted version341.81 kBMicrosoft WordView/Open
GLGC_Supplementary_Notes_090117.docxSupporting information161.91 kBMicrosoft WordView/Open
GLGC_SUPPLEMENT_TABLES_090117.xlsxSupporting information367.1 kBMicrosoft ExcelView/Open
Title: Exome-wide association study of plasma lipids in >300,000 individuals.
Authors: Liu, DJ
Peloso, GM
Yu, H
Butterworth, AS
Wang, X
Mahajan, A
Saleheen, D
Emdin, C
Alam, D
Alves, AC
Amouyel, P
Stitziel, N
Strauch, K
Stringham, HM
Surendran, P
Tada, H
Tall, AR
Tang, H
Tardif, J-C
Taylor, KD
Bis, JC
Langenberg, C
Trompet, S
Tsao, PS
Tuomilehto, J
Tybjaerg-Hansen, A
Van Zuydam, NR
Varbo, A
Varga, TV
Virtamo, J
Waldenberger, M
Wang, N
Langsted, A
Boehnke, M
Wareham, NJ
Warren, HR
Weeke, PE
Weinstock, J
Wessel, J
Wilson, JG
Wilson, PWF
Xu, M
Yaghootkar, H
Launer, LJ
Young, R
Boerwinkle, E
Zeggini, E
Zhang, H
Zheng, NS
Zhang, W
Zhang, Y
Zhou, W
Zhou, Y
Zoledziewska, M
Lauritzen, T
Charge Diabetes Working Group
EPIC-InterAct Consortium
Bork-Jensen, J
EPIC-CVD Consortium
GOLD Consortium
VA Million Veteran Program
Howson, JMM
Danesh, J
McCarthy, MI
Cowan, CA
Liewald, DCM
Abecasis, G
Deloukas, P
Musunuru, K
Bottinger, EP
Willer, CJ
Kathiresan, S
Brandslund, I
Brown, M
Busonero, F
Caulfield, MJ
Lin, LA
Chambers, JC
Chasman, DI
Chen, YE
Chen, Y-DI
Chowdhury, R
Christensen, C
Chu, AY
Connell, JM
Cucca, F
Cupples, LA
Linneberg, A
Damrauer, SM
Davies, G
Deary, IJ
Dedoussis, G
Denny, JC
Dominiczak, A
Dubé, M-P
Ebeling, T
Eiriksdottir, G
Esko, T
Loos, RJF
Farmaki, A-E
Feitosa, MF
Ferrario, M
Ferrieres, J
Ford, I
Fornage, M
Franks, PW
Frayling, TM
Frikke-Schmidt, R
Fritsche, LG
Lu, Y
Frossard, P
Fuster, V
Ganesh, SK
Gao, W
Garcia, ME
Gieger, C
Giulianini, F
Goodarzi, MO
Grallert, H
Grarup, N
Lu, X
Groop, L
Grove, ML
Gudnason, V
Hansen, T
Harris, TB
Hayward, C
Hirschhorn, JN
Holmen, OL
Huffman, J
Huo, Y
Di Angelantonio, E
Hveem, K
Jabeen, S
Jackson, AU
Jakobsdottir, J
Jarvelin, M-R
Jensen, GB
Jørgensen, ME
Jukema, JW
Justesen, JM
Kamstrup, PR
Mägi, R
Kanoni, S
Karpe, F
Kee, F
Khera, AV
Klarin, D
Koistinen, HA
Kooner, JS
Kooperberg, C
Kuulasmaa, K
Kuusisto, J
Malarstig, A
Laakso, M
Lakka, T
Manichaikul, A
Manning, AK
Mäntyselkä, P
Marouli, E
Masca, NGD
Maschio, A
Meigs, JB
Melander, O
Arveiler, D
Metspalu, A
Morris, AP
Morrison, AC
Mulas, A
Müller-Nurasyid, M
Munroe, PB
Neville, MJ
Nielsen, JB
Nielsen, SF
Nordestgaard, BG
Assimes, TL
Ordovas, JM
Mehran, R
O'Donnell, CJ
Orho-Melander, M
Molony, CM
Muntendam, P
Padmanabhan, S
Palmer, CNA
Pasko, D
Patel, AP
Auer, PL
Pedersen, O
Perola, M
Peters, A
Pisinger, C
Pistis, G
Polasek, O
Poulter, N
Psaty, BM
Rader, DJ
Rasheed, A
Baber, U
Rauramaa, R
Reilly, DF
Reiner, AP
Renström, F
Rich, SS
Ridker, PM
Rioux, JD
Robertson, NR
Roden, DM
Rotter, JI
Ballantyne, CM
Rudan, I
Salomaa, V
Samani, NJ
Sanna, S
Sattar, N
Schmidt, EM
Scott, RA
Sever, P
Sevilla, RS
Shaffer, CM
Bang, LE
Sim, X
Sivapalaratnam, S
Small, KS
Smith, AV
Smith, BH
Somayajula, S
Southam, L
Spector, TD
Speliotes, EK
Starr, JM
Benn, M
Stirrups, KE
Item Type: Journal Article
Abstract: We screened variants on an exome-focused genotyping array in >300,000 participants (replication in >280,000 participants) and identified 444 independent variants in 250 loci significantly associated with total cholesterol (TC), high-density-lipoprotein cholesterol (HDL-C), low-density-lipoprotein cholesterol (LDL-C), and/or triglycerides (TG). At two loci (JAK2 and A1CF), experimental analysis in mice showed lipid changes consistent with the human data. We also found that: (i) beta-thalassemia trait carriers displayed lower TC and were protected from coronary artery disease (CAD); (ii) excluding the CETP locus, there was not a predictable relationship between plasma HDL-C and risk for age-related macular degeneration; (iii) only some mechanisms of lowering LDL-C appeared to increase risk for type 2 diabetes (T2D); and (iv) TG-lowering alleles involved in hepatic production of TG-rich lipoproteins (TM6SF2 and PNPLA3) tracked with higher liver fat, higher risk for T2D, and lower risk for CAD, whereas TG-lowering alleles involved in peripheral lipolysis (LPL and ANGPTL4) had no effect on liver fat but decreased risks for both T2D and CAD.
Issue Date: 30-Oct-2017
Date of Acceptance: 26-Sep-2017
URI: http://hdl.handle.net/10044/1/53907
DOI: https://dx.doi.org/10.1038/ng.3977
ISSN: 1061-4036
Publisher: Nature Publishing Group
Start Page: 1758
End Page: 1766
Journal / Book Title: Nature Genetics
Volume: 49
Copyright Statement: Copyright © 2017, Rights Managed by Nature Publishing Group
Keywords: Science & Technology
Life Sciences & Biomedicine
Genetics & Heredity
APOBEC-1 COMPLEMENTATION FACTOR
CODING-SEQUENCE VARIANTS
TYROSINE KINASE JAK2
B MESSENGER-RNA
MACULAR DEGENERATION
GENETIC ARCHITECTURE
LOW-FREQUENCY
MYELOPROLIFERATIVE DISORDERS
CARDIOVASCULAR-DISEASE
CLONAL HEMATOPOIESIS
Coronary Artery Disease
Diabetes Mellitus, Type 2
Exome
Genetic Association Studies
Genetic Predisposition to Disease
Genetic Variation
Genotype
Humans
Lipids
Macular Degeneration
Phenotype
Risk Factors
Charge Diabetes Working Group
EPIC-InterAct Consortium
EPIC-CVD Consortium
GOLD Consortium
VA Million Veteran Program
11 Medical And Health Sciences
06 Biological Sciences
Developmental Biology
Publication Status: Published online
Appears in Collections:National Heart and Lung Institute